1 suspended. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Suspended 1 |
Follow Refractory Childhood Osteosarcoma: new trials by email Literature Review of Refractory Childhood Osteosarcoma trials Research Report on Refractory Childhood Osteosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, GD2-CAR PERSIST Trial Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - Recurrent Childhood Neuroblastoma, Recurrent Childhood Osteosarcoma | Phase 1 | Suspended | National Cancer Institute (NCI) | 73 | 2022-01-25 | 2026-08-05 |
Neuroblastoma (1) · Osteosarcoma (1)
Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms, Bone Tissue (1) · Neoplasms, Connective Tissue (1) · Neoplasms, Connective and Soft Tissue (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Neuroectodermal Tumors (1) · Neuroectodermal Tumors, Primitive (1) · Neuroectodermal Tumors, Primitive, Peripheral (1) · Sarcoma (1)
Biopsy (1) · Cyclophosphamide (1) · Specimen Handling (1) · X-Rays (1) · fludarabine phosphate (1)
National Cancer Institute (NCI) (1)
United States (1)
U24CA224309 (1), UM1CA154967 (1), UM1CA228823 (1)